|The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption|
AK Davis, JP Barsuglia, R Lancelotta, RM Grant, E Renn
Journal of Psychopharmacology 32 (7), 779-792, 2018
|5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety|
AK Davis, S So, R Lancelotta, JP Barsuglia, RR Griffiths
The American journal of drug and alcohol abuse 45 (2), 161-169, 2019
|Intensity of mystical experiences occasioned by 5-MeO-DMT and comparison with a prior psilocybin study|
J Barsuglia, AK Davis, R Palmer, R Lancelotta, AM Windham-Herman, ...
Frontiers in psychology 9, 2459, 2018
|Evaluation of emotional blunting in behavioral variant frontotemporal dementia compared to Alzheimer's disease|
A Joshi, JP Barsuglia, MJ Mather, EE Jimenez, J Shapira, MF Mendez
Dementia and geriatric cognitive disorders 38 (1-2), 79-88, 2014
|A scale of socioemotional dysfunction in frontotemporal dementia|
JP Barsuglia, NC Kaiser, SS Wilkins, A Joshi, RJ Barrows, P Paholpak, ...
Archives of Clinical Neuropsychology 29 (8), 793-805, 2014
|Neuropsychological and neuroanatomical correlates of the social norms questionnaire in frontotemporal dementia versus alzheimer’s disease|
H Panchal, P Paholpak, G Lee, A Carr, JP Barsuglia, M Mather, ...
American Journal of Alzheimer's Disease & Other Dementias« 31 (4), 326-332, 2016
|Subjective effectiveness of ibogaine treatment for problematic opioid consumption: short-and long-term outcomes and current psychological functioning|
AK Davis, JP Barsuglia, AM Windham-Herman, M Lynch, M Polanco
Journal of psychedelic studies 1 (2), 65-73, 2017
|Changes in withdrawal and craving scores in participants undergoing opioid detoxification utilizing ibogaine|
BJ Malcolm, M Polanco, JP Barsuglia
Journal of psychoactive drugs 50 (3), 256-265, 2018
|Observational themes of social behavioral disturbances in frontotemporal dementia|
JP Barsuglia, FR Nedjat-Haiem, JS Shapira, C Velasco, EE Jimenez, ...
International psychogeriatrics 26 (9), 1475-1481, 2014
|Executive abilities as reflected by clock hand placement: frontotemporal dementia versus early-onset Alzheimer disease|
RJ Barrows, J Barsuglia, P Paholpak, D Eknoyan, V Sabodash, GJ Lee, ...
Journal of geriatric psychiatry and neurology 28 (4), 239-248, 2015
|A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder|
JP Barsuglia, M Polanco, R Palmer, BJ Malcolm, B Kelmendi, T Calvey
Progress in brain research 242, 121-158, 2018
|Person-based versus generalized impulsivity disinhibition in frontotemporal dementia and Alzheimer disease|
P Paholpak, AR Carr, JP Barsuglia, RJ Barrows, E Jimenez, GJ Lee, ...
Journal of geriatric psychiatry and neurology 29 (6), 344-351, 2016
|Rich club network analysis shows distinct patterns of disruption in frontotemporal dementia and Alzheimer’s disease|
M Daianu, N Jahanshad, JE Villalon-Reina, MF Mendez, G Bartzokis, ...
Computational Diffusion MRI, 13-22, 2014
|Characterization of mystical experiences occasioned by 5-MeO-DMT-containing toad bufotoxin and comparison with prior psilocybin studies|
J Barsuglia, A Davis, R Palmer
Psychedelic Sci 23, 2017
|Psychedelic treatment for trauma-related psychological and cognitive impairment among US Special Operations Forces Veterans|
AK Davis, LA Averill, ND Sepeda, JP Barsuglia, T Amoroso
Chronic Stress 4, 2470547020939564, 2020
|A mixed-method analysis of persisting effects associated with positive outcomes following ibogaine detoxification|
AK Davis, E Renn, AM Windham-Herman, M Polanco, JP Barsuglia
Journal of psychoactive drugs 50 (4), 287-297, 2018
|A phenomenological investigation into the lived experience of ibogaine and its potential to treat opioid use disorders|
TJ Camlin, D Eulert, A Thomas Horvath, SF Bucky, JP Barsuglia, ...
Journal of Psychedelic Studies 2 (1), 24-35, 2018
|Subjective improvements in substance use problems following 5-MeO-DMT use in an international sample|
KE Cox, SA Moshman, JP Barsuglia, R Lancelotta, AK Davis
Poster session presented at the Annual Poster Symposium of the Behavioralá…, 2018
|5-MeO-DMT and subjective improvements in post traumatic stress disorder|
KE Cox, R Lancelotta, JP Barsuglia, AK Davis
annual conference of the Maryland Psychological Association, Baltimore, MD, 2018
|Regional Atrophy and Nonverbal Semantic Memory in Behavioral Variant Frontotemporal Dementia And Alzheimer’s Disease|
JP Barsuglia, H Panchal, G Lee, P Lu, S Wilkins, A Joshi, M Mather, ...
Washington, DC: American Psychological Association Annual Conference, 2014